Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business
Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business
Whole Genome Analysis Leads To Faster Diagnosis And Cost Benefits
Whole Genome Analysis Leads To Faster Diagnosis And Cost Benefits
Congenica Expands in North America with Strategic Appointment
Congenica Expands in North America with Strategic Appointment
Elucigene partners with Congenica on new NGS cystic fibrosis kit
Elucigene partners with Congenica on new NGS cystic fibrosis kit
Sapientia helps manage ten-fold increase in demand for genomic analysis
Sapientia helps manage ten-fold increase in demand for genomic analysis
Congenica Detecting Clinically Relevant Variants In 35% Of First Diagnostic Reports Delivered To UK 100,000 Genomes Project
Sapientia Detecting Clinically Relevant Variants In 35% Of First Diagnostic Reports Delivered To UK 100,000 Genomes Project
Consistency and data sharing vital to unlock value of genetic testing says Congenica’s Dr Matthew Hurles
Consistency and data sharing vital to unlock value of genetic testing says Congenica’s Dr Matthew Hurles
100,000 Genomes Project: Congenica first UK company to deliver diagnostic reports
100,000 Genomes Project: Congenica first UK company to deliver diagnostic reports
New karyogram display improves Sapientia for clinical diagnosis
New karyogram display improves Sapientia for clinical diagnosis
Congenica’s Sapientia selected for ‘PAGE’ prenatal genetic testing project
Congenica’s Sapientia selected for ‘PAGE’ prenatal genetic testing project
Congenica wins NHS innovation competition with Sapientia™
Congenica wins NHS innovation competition with Sapientia™
Birmingham Women’s Hospital leads the way in genomic diagnosis
Birmingham Women’s Hospital leads the way in genomic diagnosis